Impact of apremilast on quality of life in Behçet’s syndrome: analysis of the phase 3 RELIEF study

Impact of apremilast on quality of life in Behçet’s syndrome: analysis of the phase 3 RELIEF study

Objective To assess apremilast’s impact on patient quality of life (QoL) in active Behçet’s syndrome and correlations between improvement in patients’ QoL and efficacy measures in the phase 3 RELIEF study.Methods QoL measures included Behçet’s Disease QoL (BDQoL), 36-Item Short-Form Health Survey V....

Full description

Bibliographic Details
Main Authors: Gulen Hatemi, Alfred Mahr, Yusuf Yazici, Melike Melikoğlu, Mitsuhiro Takeno, Maria Paris, Doyoung Kim, Sue Cheng, Shannon McCue, Mindy Chen
Format: Article
Language:English
Published: BMJ Publishing Group 2022-07-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/8/2/e002235.full

Internet

https://rmdopen.bmj.com/content/8/2/e002235.full

Similar Items